Question · Q4 2025
Joel Hurwitz inquired about the rate actions taken for RGA's U.S. Group health business in 2026, the decision to exit this business line, its overall size, and expected run rate earnings. He also asked for an update on RGA's appetite for de-risking legacy blocks like long-term care (LTC) and universal life with secondary guarantees (ULSG).
Answer
EVP and CFO Axel André detailed a 40% average rate increase for the U.S. healthcare excess book, effective mid-2025 through January 2026, and announced the decision to exit group healthcare lines, which have approximately $400 million in annual premium and $25 million in pre-tax run rate earnings. President and CEO Tony Cheng stated RGA remains selective and disciplined on ULSG and LTC risk, requiring higher hurdle rates, and noted these liabilities are less than 10% of the balance sheet.
Ask follow-up questions
Fintool can predict
RGA's earnings beat/miss a week before the call